Cangrelor intermediate 163706-61-4
Product Quick Detail
- Minimum Order
- 1
- Packaging
- 1kg/Fluoride bottle
- Delivery
- 15 Days
Specifications
We manufacture and provide Cangrelor intermediate
CAS 163706-61-4
Purity is ≥ 98%
Cangrelor:
is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application. Some P2Y12 inhibitors are used
clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation.
- Country: China (Mainland)
- Business Type:
- Market:
- Founded Year:2013
- Address:Building 9, No. 150, Cailun Road, Zhangjiang High-Tech Park, Shanghai, China
- Contact:Chrissy Chen
Other products from Shanghai Bocimed Pharmaceutical Co., Ltd.
Relate products of Cangrelor intermediate 163706-61-4
Cangrelor intermediate 10596-22-2
We manufacture and provide Cangrelor intermediate CAS 10596-22-2 Purity is ≥ 98% Cangrelor: is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application. Some P2Y12 inhibitors are used clinically as effective inhibitors of adenosine ...
